CAMBRIDGE, Mass., May 14 /PRNewswire-FirstCall/ -- Biopure Corporation
(Nasdaq: BPUR) today announced it has appointed Dechra Veterinary Products
as exclusive distributor for Oxyglobin(R) solution [hemoglobin glutamer-200
(bovine)] or HBOC-301, in the U.S. Oxyglobin is the only FDA-approved
treatment for canine anemia, a potentially life-threatening condition.
Under the terms of the agreement, Dechra will market Oxyglobin in 60 mL
single dose and 125 mL single dose infusion bags, and Biopure will continue
to manufacture Oxyglobin.
"We look forward to mutual success with Dechra to have Oxyglobin reach
its market potential," stated Barry Scott, Vice President, Business
Development of Biopure. "We selected Dechra because it has been successful
at developing its presence in the U.S. veterinary market with FDA approved
products for companion animals."
Dechra Veterinary Products is a division of Dechra Pharmaceuticals PLC,
a UK Stock Exchange Listed Company in international animal healthcare
marketing. For more information about Oxyglobin, see
http://www.oxyglobin.com or http://www.dechra-us.com. More information
about Dechra Pharmaceuticals PLC can be found at http://www.dechra.com.
Biopure Corporation
Biopure Corporation develops, manufactures and markets pharmaceuticals,
called oxygen therapeutics, that are intravenously administered to deliver
oxygen to the body's tissues. Hemopure(R) [hemoglobin glutamer - 250
(bovine)], or HBOC-201, is approved for sale in South Africa for the
treatment of surgical patients who are acutely anemic. Biopure's veterinary
product Oxyglobin(R) [hemoglobin glutamer - 200 (bovine)], or HBOC-301, the
only oxygen therapeutic approved for marketing by both the U.S. Food and
Drug Administration and the European Commission, is indicated for the
treatment of anemia in dogs. Biopure has sold approximately 200,000 units
of Oxyglobin since the product's launch in 1998.
Contact: Tiana Gorham
Biopure Corporation
(617) 234-6826
IR@biopure.com
SOURCE Biopure Corporation
 back to top
Related links:
http://www.biopure.com
http://www.oxyglobin.com http://www.dechra-us.com
http://www.dechra.com
http://www.prnewswire.com/comp/131224.html /
CONTACT:
Tiana Gorham of Biopure Corporation,
+1-617-234-6826, IR@biopure.com
|
